Suggestions
Jonathan MacQuitty
CEO at D2G Biotech
Jonathan MacQuitty is a highly experienced executive in the life sciences and healthcare sectors, currently serving as the CEO of D2G Biotech.3 With over three decades of experience in the industry, Dr. MacQuitty has held various leadership roles and made significant contributions to the field.12
Professional Background
Current Positions::
- CEO of D2G Biotech (also referred to as D2G Oncology)136
- Venture Partner at Lightspeed Venture Partners25
- Chairman of the Board of Personalis1
Previous Roles::
- Founding CEO of Forty Seven, Inc., an immuno-oncology company12
- Partner at Abingworth Management Inc., a trans-Atlantic bio-investment firm12
- Founding CEO of GenPharm International, a biotech company developing a human sequence antibody platform12
Education and Expertise
Dr. MacQuitty holds a Ph.D. in Chemistry from the University of Sussex and an M.B.A. from the Stanford Graduate School of Business.1 His expertise spans various aspects of the life science and healthcare sectors, including venture capital, biotechnology, and oncology.
Entrepreneurial and Investment Experience
Throughout his career, Dr. MacQuitty has demonstrated a strong track record in company formation, entrepreneurship, and venture capital. He has been involved in founding and leading multiple biotech companies, as well as investing in and advising life science startups.124
Personal Interests
Outside of his professional life, Dr. MacQuitty is known to enjoy competitive contract bridge as a hobby.2
Jonathan MacQuitty's LinkedIn profile can be found under the username jonathan-macquitty-51b397185.3
